News | 16 May 2012
Of all the sectors in the stock market, no sector moves more due to corporate developments than the biotechnology sector. A single drug trial or FDA decision can send stocks soaring, or plunging. Due to this trend, many investors choose to trade ...
Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)